Generic Industry Wary of New Packaging for Opioids; Contend it Could Delay Entry

The generic drug industry wants the FDA to ensure new requirements for packaging and technologies aimed at curbing opioid abuse don’t result in barriers to market entry for generic makers.
Generic Line